In the Indian patent law, the sufficiency of disclosure requirement is codified under Section 10 (4) of the Patents Act, 1970 ...

Global Phase 3 BRAVE study will evaluate the efficacy and safety of omaveloxolone in children 2 to BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the ped ...